All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

236

Reset

236 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ND0612ND0612HPhase 21 trial

    NeuroDerm Ltd. · Parkinson's Disease

  • NEU-411Phase 21 trial

    Neuron23 Inc. · Parkinson Disease, Parkinson, Idiopathic Parkinson Disease

  • NPT 2042Phase 21 trial

    NeuroPro Therapeutics, Inc. · Epilepsy, Generalized, Epilepsy, Absence

  • NS-050NCNP-03Phase 21 trial

    NS Pharma, Inc. · Duchenne Muscular Dystrophy

  • NSC001Phase 21 trial

    NSC-Therapeutics · Alzheimer Disease

  • NTRX-07MDA7Phase 21 trial

    NeuroTherapia, Inc. · Alzheimer Disease, Mild Cognitive Impairment

  • NX210cPhase 21 trial

    Axoltis Pharma · Amyotrophic Lateral Sclerosis

  • NYX-458Phase 21 trial

    Aptinyx · Mild Cognitive Impairment, Mild Dementia, Parkinson Disease

  • PIPE-307Phase 21 trial

    Johnson & Johnson (Janssen) · Relapsing Remitting Multiple Sclerosis

  • PLL001Phase 21 trial

    PLL TX AUSTRALIA PTY LTD · Amyotrophic Lateral Sclerosis, ALS

  • PRI-002ContraloidPhase 21 trial

    PRInnovation GmbH · Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease, Early Onset

  • PRO-1562Phase 21 trial

    Progentos Therapeutics · Multiple Sclerosis

  • PRT-064040Phase 21 trial

    Sichuan Purity Pharmaceutical Technology Co., Ltd. · Migraine

  • RenadirsenDS-5141bPhase 21 trial

    Daiichi Sankyo · Duchenne Muscular Dystrophy

  • RinvaterceptKER-065Phase 21 trial

    Keros Therapeutics, Inc. · Duchenne Muscular Dystrophy

  • RNDP-001Phase 21 trial

    Kenai Therapeutics · Idiopathic Parkinson´s Disease, Parkinson's Disease

  • RO7268489Phase 21 trial

    Roche (Genentech) · Progressive Multiple Sclerosis

  • RO7269162Phase 21 trial

    Roche (Genentech) · Alzheimer's Disease

  • sabirnetugPhase 21 trial

    Acumen Pharmaceuticals · Alzheimer Disease

  • SAR448851Phase 21 trial

    Sanofi · Dementia, Alzheimer's Type, Alzheimer's Disease

  • SIR2501Phase 21 trial

    Sironax USA, Inc. · Chemotherapy-induced Peripheral Neuropathy

  • SNUG01Phase 21 trial

    SineuGene Therapeutics Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • SUL-238t.i.d.Phase 21 trial

    GEN İlaç ve Sağlık Ürünleri A.Ş. · Parkinson's Disease (PD)

  • SUN-627NEU-627, N-004850Phase 21 trial

    Sundance Biosciences, Inc. · Primary Progressive Multiple Sclerosis, Primary Progressive MS, Primary Progressive Multiple Sclerosis (PPMS)

  • TAK-411Hypersialylated Immune Globulin GPhase 21 trial

    Takeda · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

  • TB006Phase 21 trial

    TrueBinding, Inc. · Parkinson's Disease (PD)

  • TominersenRO7234292, RG6042Phase 21 trial

    Roche (Genentech) · Huntington Disease

  • TRCN-1023Phase 21 trial

    Trace Neuroscience, Inc. · Amyotrophic Lateral Sclerosis

  • TRX319Phase 21 trial

    Tr1X, Inc. · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Multiple Sclerosis

  • UCB0022Phase 21 trial

    UCB · Parkinson Disease

  • VMD-3866Phase 21 trial

    VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy

  • VO659Phase 21 trial

    Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease

  • VT7208Phase 21 trial

    Vidya Therapeutics Inc · Multiple Sclerosis

  • VY7523Phase 21 trial

    Voyager Therapeutics · Alzheimer's Disease (AD)

  • XJN010Phase 21 trial

    Guangzhou Novaken Pharm Co., Ltd. · Parkinson Disease

  • XPro1595INB03, XProPhase 21 trial

    Inmune Bio, Inc. · Alzheimer Disease, Dementia, Brain Diseases

NewerPage 5 of 5

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.